The reporter will seek to explain to an audience of professional and retail investors/ consumers how companies are dealing with changes in policy and hardening public attitudes to such issues as rising drug prices and the higher cost of coverage. The right candidate will have an interest in the latest research into major diseases and the new therapies and technologies being developed.
They will have a passion for digging into financials, including earnings releases and regulatory filings, to find the companies expected to lead in their sector in the coming years. This reporter will also have a clear writing style that allows them to explain the intricacies of the U.S. health care system and the companies that serve it.
This reporter should have at least five years of experience, ideally with a background covering business and financial news. The position is based in New York.
PCWorld executive editor Gordon Mah Ung, a tireless journalist we once described as a founding father…
CNBC senior vice president Dan Colarusso sent out the following on Monday: Before this year comes to…
Business Insider editor in chief Jamie Heller sent out the following on Monday: I'm excited to share…
Former CoinDesk editorial staffer Michael McSweeney writes about the recent happenings at the cryptocurrency news site, where…
Manas Pratap Singh, finance editor for LinkedIn News Europe, has left for a new opportunity…
Washington Post executive editor Matt Murray sent out the following on Friday: Dear All, Over the last…